The cancer system gives patients options but no framework for making sense of them

Personalised cancer care is increasingly framed around more tests, more treatments, and more data – but patients are often left to navigate fragmented information under enormous pressure, with limited guidance and almost no integration between conventional and complementary approaches. Dale is building Beyond the Standard, a charity alongside Jane McLelland (author of How to Starve Cancer), to advocate for systemic change: better access to evidence-led complementary treatments, routine genomic testing, and care models that treat the patient as a decision-maker rather than a passive recipient. He speaks about this not as a campaigner but as someone who commissioned his own genomic sequencing, built a daily protocol of 40+ supplements and repurposed pharmaceuticals, and writes about the evidence on The Life Organic. For integrative healthcare providers, healthcare leaders, and patient advocacy audiences, this opens a practical conversation about what patient-centred actually means when the stakes are life and death.

About Dale Atkinson

Dale Atkinson, podcast guest

Founder, Clear Signal Partners Helping healthcare businesses find and fix the trust failures that cost them patients.

Nearly 20 years Compliance, governance & financial crime experience£500K Spent navigating private healthcare alongside NHS treatmentHundreds Patients spoken with about healthcare experiencesHIMSS Europe 2026 Speaker

Dale Atkinson is the founder of Clear Signal Partners, a healthcare consultancy that audits the patient experience from the outside in. His flagship methodology – the Patient Trust Audit – puts him through a client’s patient journey as a real prospective patient, with no insider knowledge, and reports back exactly where trust breaks down and what it’s costing them.

What makes Dale’s perspective unusual is where it comes from. He spent nearly two decades in compliance, governance, and financial crime across HSBC, Wellington Management, Schroders, and Deutsche Bank – chairing committees, running global teams, and building trust frameworks inside regulated institutions. In October 2024, he was diagnosed with Stage IV oesophageal cancer – inoperable, incurable, given less than a year. He found himself on the other side of a trust system, and the gaps were worse than anything he’d seen in financial services.

Since diagnosis, Dale has spent nearly half a million pounds navigating private healthcare alongside NHS treatment, building his own integrative protocol, and speaking to hundreds of patients with similar experiences. That combination – regulated governance professional, Stage IV cancer patient, and active private healthcare consumer – is the lens through which Clear Signal Partners operates. No one else is auditing healthcare trust from that intersection.

View profile →

Book Dale Atkinson for your show

11+ podcast & stage appearances. Remote or in studio, broadcast-grade audio.

Request an interview →
Eps 82. Stage 4 Cancer: Why I Didn't Accept "Incurable" | Dale Atkinson
0:00 / 42:54
Functionally Enlightened - Better ways to heal from chronic pain and illness· Listen to Dale Atkinson on air